BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 24283290)

  • 1. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
    Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
    FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardin inhibits estrogen receptor alpha-mediated proliferation of human breast cancer MCF-7 cells via regulating MicroRNA expression.
    Xiang Y; Lu DL; Li JP; Yu CX; Zheng DL; Huang X; Wang ZY; Hu P; Liao XH; Zhang TC
    IUBMB Life; 2016 Jun; 68(6):477-87. PubMed ID: 27156566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
    Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
    Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
    Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
    Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines.
    Tan H; Zhong Y; Pan Z
    BMC Cancer; 2009 Jan; 9():31. PubMed ID: 19171042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzophenone-1 and nonylphenol stimulated MCF-7 breast cancer growth by regulating cell cycle and metastasis-related genes via an estrogen receptor α-dependent pathway.
    In SJ; Kim SH; Go RE; Hwang KA; Choi KC
    J Toxicol Environ Health A; 2015; 78(8):492-505. PubMed ID: 25849766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy.
    Liu W; Ip MM; Podgorsak MB; Das GM
    Breast Cancer Res Treat; 2009 May; 115(1):43-50. PubMed ID: 18481172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells.
    Peng J; Jordan VC
    Int J Oncol; 2010 Feb; 36(2):451-8. PubMed ID: 20043081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of estrogen receptor and p21(Waf1) in bortezomib-induced growth inhibition in human breast cancer cells.
    Maynadier M; Shi J; Vaillant O; Gary-Bobo M; Basile I; Gleizes M; Cathiard AM; Wah JL; Sheikh MS; Garcia M
    Mol Cancer Res; 2012 Nov; 10(11):1473-81. PubMed ID: 22964432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.
    Zhong J; Cao RX; Zu XY; Hong T; Yang J; Liu L; Xiao XH; Ding WJ; Zhao Q; Liu JH; Wen GB
    FEBS J; 2012 Jan; 279(2):316-35. PubMed ID: 22093364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptotic cell death by phytoestrogens by up-regulating the levels of phospho-p53 and p21 in normal and malignant estrogen receptor α-negative breast cells.
    Seo HS; Ju JH; Jang K; Shin I
    Nutr Res; 2011 Feb; 31(2):139-46. PubMed ID: 21419318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells.
    Wang C; Yu J; Kallen CB
    PLoS One; 2008; 3(10):e3523. PubMed ID: 18949048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.
    Kim K; Madak-Erdogan Z; Ventrella R; Katzenellenbogen BS
    Horm Cancer; 2013 Apr; 4(2):78-91. PubMed ID: 23250869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annonacin induces cell cycle-dependent growth arrest and apoptosis in estrogen receptor-α-related pathways in MCF-7 cells.
    Ko YM; Wu TY; Wu YC; Chang FR; Guh JY; Chuang LY
    J Ethnopharmacol; 2011 Oct; 137(3):1283-90. PubMed ID: 21840388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation.
    Gu G; Barone I; Gelsomino L; Giordano C; Bonofiglio D; Statti G; Menichini F; Catalano S; Andò S
    J Cell Physiol; 2012 Oct; 227(10):3363-72. PubMed ID: 22213398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.